Literature DB >> 15912557

Proteome profile of human urine with two-dimensional liquid phase fractionation.

Monica Soldi1, Cecilia Sarto, Cristina Valsecchi, Fulvio Magni, Vanessa Proserpio, Davide Ticozzi, Paolo Mocarelli.   

Abstract

Two-dimensional liquid chromatography separation (2-DL), based on chromatofocusing for first dimension and hydrophobicity for second, can be used as a complementary method to two-dimensional gel electrophoresis (2-DE). A platform now available, ProteomeLab PF 2D provided by Beckman Coulter, (Fullerton, CA, USA), assembles these methods in automation. This system was applied to resolve large numbers of urine proteins. Reproducibility and sensitivity in protein resolution were evaluated in this study using urines collected from male blood donors. About 1000 peaks were detected at a pH range of 4.0-8.5 by applying 1 mg of proteins. Furthermore, the same fractions showing peaks with high absorbance intensities in second dimension were collected and subjected to matrix-assisted laser desorption/ionization-time of flight/mass spectrometry analysis for identification. The results showed that the 2-DL provides high reproducibility of two-dimensional protein map, and lends fractions to subsequent mass spectrometry analysis without the further need for extraction or solubilization of samples as required for spots excised from 2-DE gels. In addition, this system also allows to separate particularly proteins with 40-9 kDa molecular weight.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15912557     DOI: 10.1002/pmic.200401269

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  15 in total

1.  Rapid T cell-based identification of human tumor tissue antigens by automated two-dimensional protein fractionation.

Authors:  Philipp Beckhove; Rolf Warta; Britt Lemke; Diana Stoycheva; Frank Momburg; Martina Schnölzer; Uwe Warnken; Hubertus Schmitz-Winnenthal; Rezvan Ahmadi; Gerhard Dyckhoff; Mariana Bucur; Simone Jünger; Thomas Schueler; Volker Lennerz; Thomas Woelfel; Andreas Unterberg; Christel Herold-Mende
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

2.  A method for isolation and identification of urinary biomarkers in patients with diabetic nephropathy.

Authors:  Wayne G Fisher; Jessica E Lucas; Uzma F Mehdi; Danna W Qunibi; Harold R Garner; Kevin P Rosenblatt; Robert D Toto
Journal:  Proteomics Clin Appl       Date:  2011-12       Impact factor: 3.494

Review 3.  Urine collection and processing for protein biomarker discovery and quantification.

Authors:  C Eric Thomas; Wade Sexton; Kaaron Benson; Rebecca Sutphen; John Koomen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-23       Impact factor: 4.254

4.  Going from genes to proteins in myelodysplastic syndromes.

Authors:  Arnold Ganser; Michael A Morgan; Eva M Weissinger
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-19       Impact factor: 11.205

Review 5.  Mass spectrometry based proteomics in urine biomarker discovery.

Authors:  Dan Theodorescu; Harald Mischak
Journal:  World J Urol       Date:  2007-08-17       Impact factor: 4.226

6.  High-resolution proteome/peptidome analysis of peptides and low-molecular-weight proteins in urine.

Authors:  Harald Mischak; Bruce A Julian; Jan Novak
Journal:  Proteomics Clin Appl       Date:  2007-07-10       Impact factor: 3.494

7.  Haptoglobin is a serological biomarker for adenocarcinoma lung cancer by using the ProteomeLab PF2D combined with mass spectrometry.

Authors:  You-Kang Chang; Yu-Heng Lai; Yen Chu; Ming-Cheng Lee; Chun-Yao Huang; Semon Wu
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

8.  Proteomic based investigation of rhamnolipid production by Pseudomonas chlororaphis strain NRRL B-30761.

Authors:  Nereus W Gunther; Alberto Nuñez; Laurie Fortis; Daniel K Y Solaiman
Journal:  J Ind Microbiol Biotechnol       Date:  2006-09-09       Impact factor: 3.346

Review 9.  Key clinical issues in renal cancer: a challenge for proteomics.

Authors:  Rosamonde E Banks; Rachel A Craven; Patricia Harnden; Sanjeev Madaan; Adrian Joyce; Peter J Selby
Journal:  World J Urol       Date:  2007-08-25       Impact factor: 4.226

Review 10.  Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform.

Authors:  Eric Schiffer; Harald Mischak; Dan Theodorescu; Antonia Vlahou
Journal:  World J Urol       Date:  2008-01-04       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.